Evidence map›Paper›PMID 41253649›Full record

ArticleThe journal of prevention of Alzheimer's disease2026

Erratum to "Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers" [The Journal of Prevention of Alzheimer's Disease volume 12 (2025) 100302].

Flavia C Nery, Maciej Kaliszczak, Ben Suttle, Lori Jones, Shuang Wu, Jing Xie, Gioacchino Curiale, Esin Yesilalan, Beth Hirschhorn, Denisa Wilkes and 13 more

Abstract readPublished Erratum
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Flavia C NeryBiogen, Cambridge, MA, USA. Electronic address: flavia.neryodonnell@biogen.com.
Maciej KaliszczakBiogen, Cambridge, MA, USA.
Ben SuttleBiogen, Durham, NC, USA; qPharmetra, Raleigh, NC, USA.
Lori JonesBiogen, Durham, NC, USA.
Shuang WuBiogen, Cambridge, MA, USA.
Jing XieBiogen, Cambridge, MA, USA.
Gioacchino CurialeBiogen, Cambridge, MA, USA.
Esin YesilalanBiogen, Cambridge, MA, USA.
Beth HirschhornBiogen, Cambridge, MA, USA.
Denisa WilkesHammersmith Medicines Research Limited, London, UK.
Dave SinghMedicines Evaluation Unit, The Langley Building, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK.
Martin BolinDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Sangram NagDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Andrea VarroneDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Per StenkronaDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Anton Forsberg MorénDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Christer HalldinDepartment of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Jeffrey YachninKarolinska Comprehensive Cancer Center, Huddinge, Sweden.
H Moore ArnoldBiogen, Cambridge, MA, USA.
Szofia BullainBiogen, Cambridge, MA, USA.
Jaren LandenBiogen, Cambridge, MA, USA.
Diana GallagherBiogen, Cambridge, MA, USA.
Heike HeringBiogen, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41253649
PMCPMC12811761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.